PPARA and steatosis: DLPCBs activate the aryl hydrocarbon receptor (AhR) and peroxisome proliferator-activated receptors alpha and gamma (PPARα/γ) (63, 68), exerting a multimodal effect on lipid accumulation and causing steatosis by disrupting liver lipid metabolism.